Bacterial Infections
Information
- Disease name
- Bacterial Infections
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06419426 | Active, not recruiting | Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo) | April 22, 2020 | December 31, 2024 | |
| NCT03896685 | Active, not recruiting | Phase 3 | Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) | April 6, 2020 | November 2024 |
| NCT03424525 | Active, not recruiting | Phase 1 | 11C-Trimethoprim PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects | February 1, 2018 | December 2024 |
| NCT06211829 | Active, not recruiting | An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections | May 18, 2022 | May 18, 2024 | |
| NCT05641025 | Active, not recruiting | Prediction of Multidrug-resistant Bacterial Infection in Patients With Cirrhosis | November 16, 2022 | January 30, 2023 | |
| NCT03780140 | Approved for marketing | Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections | |||
| NCT00035854 | Completed | Phase 3 | New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) | February 2002 | May 2004 |
| NCT00037050 | Completed | Phase 3 | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria | April 2002 | July 2005 |
| NCT00044928 | Completed | Phase 4 | Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection | July 2002 | February 2004 |
| NCT00100308 | Completed | Phase 3 | Unfractioned Heparin for Treatment of Sepsis | July 2005 | July 2007 |
| NCT00205816 | Completed | Phase 3 | Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. | January 2004 | November 2005 |
| NCT00216450 | Completed | Phase 4 | Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. | October 2004 | February 2006 |
| NCT00258102 | Completed | Phase 3 | A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections | January 1993 | January 1995 |
| NCT00288418 | Completed | Phase 3 | Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization | December 2005 | July 2007 |
| NCT00318344 | Completed | Phase 1 | Evaluation of Atuna Racemosa Toxicity | April 2006 | November 2007 |
| NCT00347386 | Completed | Phase 2/Phase 3 | Therapeutic Zinc in Infant Bacterial Illness | July 2005 | December 2008 |
| NCT00353158 | Completed | Phase 1 | A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity | May 25, 2007 | September 20, 2011 |
| NCT00366249 | Completed | Phase 3 | Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. | January 2007 | March 2009 |
| NCT00410527 | Completed | Phase 4 | Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients | August 11, 2006 | May 22, 2007 |
| NCT00423657 | Completed | Phase 3 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | March 2007 | December 2007 |
| NCT00424190 | Completed | Phase 3 | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections | February 2007 | November 2007 |
| NCT00431483 | Completed | N/A | Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards | February 2007 | February 2008 |
| NCT00449735 | Completed | Quinolone Resistance in Bloodstream Isolates of Escherichia Coli | March 2007 | June 2017 | |
| NCT00472667 | Completed | N/A | PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA) | July 2007 | May 2008 |
| NCT00478855 | Completed | Phase 4 | Tazocin Intervention Study | September 2006 | June 2007 |
| NCT00488189 | Completed | Phase 4 | Study Evaluation Tazocin Intervention | May 2007 | February 2008 |
| NCT00488345 | Completed | Phase 2 | Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age | December 2007 | September 2009 |
| NCT00493922 | Completed | Phase 4 | Trial of Rapid Diagnostic Tests in Rural Ghana | July 2007 | June 2009 |
| NCT00515034 | Completed | Phase 2 | A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia | October 2007 | November 2008 |
| NCT00515151 | Completed | Phase 4 | Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride | May 2002 | April 2005 |
| NCT00564447 | Completed | Phase 4 | Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers | December 2007 | |
| NCT00575367 | Completed | Phase 4 | Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers | March 2008 | |
| NCT00575380 | Completed | Phase 4 | Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery | December 2007 | |
| NCT00668044 | Completed | Phase 3 | Ciprofloxacin on Burned Patients | November 2002 | November 2003 |
| NCT00670215 | Completed | Phase 3 | BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis | April 2004 | October 2004 |
| NCT00678106 | Completed | Phase 1 | Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections | September 2008 | July 2009 |
| NCT00714402 | Completed | Procalcitonin Level and Kinetics in Children With Bacterial Infections | August 2008 | ||
| NCT00736554 | Completed | What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? | July 2008 | November 2008 | |
| NCT00795145 | Completed | Phase 1 | A Study To Assess The Effect Of Linezolid On QTc Interval | December 2008 | March 2009 |
| NCT00799591 | Completed | French Study In ICU Patients Treated With Tigecycline | September 2008 | May 2010 | |
| NCT00965848 | Completed | Phase 4 | A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections | June 2009 | July 2010 |
| NCT00983255 | Completed | Phase 1 | Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) | September 2009 | January 2010 |
| NCT00998309 | Completed | Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan) | October 2009 | January 2011 | |
| NCT01018641 | Completed | Phase 1 | An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults | January 2010 | July 2011 |
| NCT01058824 | Completed | Phase 1 | Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule | April 2009 | April 2009 |
| NCT01074775 | Completed | N/A | Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection | September 2006 | September 2007 |
| NCT01111864 | Completed | N/A | Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods | February 2010 | October 2012 |
| NCT01119105 | Completed | Phase 2 | Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) | May 2010 | February 3, 2011 |
| NCT05614895 | Completed | Phase 1 | A Study to Investigate the Pharmacokinetics of RO7223280 in Critically Ill Participants With Bacterial Infections | December 3, 2022 | January 13, 2024 |
| NCT00000826 | Completed | Phase 1 | Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites | May 1999 | |
| NCT00002139 | Completed | Phase 1 | Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. | ||
| NCT00002344 | Completed | Phase 1 | A Study of Azithromycin in HIV-Infected Patients | ||
| NCT00004747 | Completed | Phase 2 | Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis | July 1995 | |
| NCT00008853 | Completed | Phase 1 | Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines | November 2005 | |
| NCT02452047 | Completed | Phase 3 | Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) | August 21, 2015 | September 18, 2017 |
| NCT02475876 | Completed | Phase 1 | PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children | November 2015 | June 30, 2020 |
| NCT02500654 | Completed | Phase 4 | Regenerative Surgical Treatment of Peri-implantitis | December 2008 | January 2014 |
| NCT02541695 | Completed | N/A | Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli | September 2015 | January 2017 |
| NCT02814916 | Completed | Phase 3 | Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA | March 31, 2017 | December 31, 2023 |
| NCT02848534 | Completed | The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections | February 6, 2016 | September 12, 2016 | |
| NCT02852902 | Completed | Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. | January 1, 2016 | January 1, 2018 | |
| NCT02877927 | Completed | Phase 3 | Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI | August 2016 | June 6, 2017 |
| NCT02955459 | Completed | Phase 1 | VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers | November 2016 | June 2017 |
| NCT02993575 | Completed | Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients | June 1, 2017 | April 1, 2018 | |
| NCT03016845 | Completed | Pharmacokinetics of Ciprofloxacin in Critically Ill Patients | January 1, 2017 | April 1, 2018 | |
| NCT03024034 | Completed | Phase 1 | A Phase 1 TP-271 Oral PK Single Ascending Dose Study | March 2, 2017 | June 4, 2018 |
| NCT03053258 | Completed | Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP) | October 2016 | February 2019 | |
| NCT03192072 | Completed | A Rapid Test for Acute Respiratory Illness | July 17, 2017 | December 19, 2019 | |
| NCT03233438 | Completed | Phase 4 | Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) | July 24, 2017 | October 30, 2018 |
| NCT03234738 | Completed | Phase 1 | A Phase 1 Safety and PK Study of IV TP-271 | August 16, 2017 | January 2, 2018 |
| NCT03332732 | Completed | Phase 1 | VNRX-5133 Drug-Drug Interaction in Healthy Adult Volunteers | October 24, 2017 | December 20, 2017 |
| NCT03361163 | Completed | Phase 1 | Controlled Human Infection for Vaccination Against Streptococcus Pyogenes | July 10, 2018 | April 21, 2020 |
| NCT03397433 | Completed | N/A | ANti-infective Stewardship Using the Wisca Tool in the Electronic Medical Record | June 15, 2015 | June 30, 2019 |
| NCT03450187 | Completed | Phase 1 | A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study | March 20, 2018 | March 31, 2019 |
| NCT03475472 | Completed | Direct Molecular Characterization of Bacteria From ICU and From the REHAB | February 1, 2018 | January 27, 2021 | |
| NCT03537664 | Completed | N/A | Adjunctive Steps for Disinfection of Teeth With Primary Endodontic Infections | August 4, 2017 | May 29, 2020 |
| NCT03590600 | Completed | Phase 1 | A Single Ascending Dose Study of BTZ043 | June 7, 2018 | March 5, 2019 |
| NCT03605498 | Completed | OR PathTrac (Tracking Intra-operative Bacterial Transmission) | September 5, 2017 | February 12, 2018 | |
| NCT03627000 | Completed | Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection | October 1, 2016 | April 1, 2018 | |
| NCT03646227 | Completed | Multi-Drug Resistant Organism Network | June 16, 2016 | May 30, 2020 | |
| NCT03696550 | Completed | Phase 1 | A Safety and PK Study of IV Eravacycline | December 20, 2018 | March 19, 2021 |
| NCT03726216 | Completed | Xydalba Utilization Registry in France | September 6, 2018 | October 28, 2020 | |
| NCT03738683 | Completed | Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients | February 1, 2019 | October 1, 2019 | |
| NCT03761043 | Completed | N/A | Nurse Promotion of IV to PO Antimicrobial Conversion | January 8, 2019 | April 7, 2019 |
| NCT03919032 | Completed | Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics | October 16, 2018 | December 31, 2019 | |
| NCT03925480 | Completed | Phase 3 | Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial | July 1, 2019 | February 28, 2023 |
| NCT03939429 | Completed | Phase 1 | Phase 1 Study of Oral QPX2015 in Healthy Adult Subjects | May 20, 2019 | October 6, 2019 |
| NCT03992703 | Completed | Clinical Impact of Rapid AST Directly From Blood Cultures | April 1, 2019 | December 31, 2020 | |
| NCT04096092 | Completed | Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients | January 15, 2020 | December 1, 2022 | |
| NCT04100772 | Completed | Phase 1 | Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above | May 18, 2020 | August 23, 2022 |
| NCT04196192 | Completed | Febrile Infants - Diagnostic Assessment and Outcome | March 1, 2020 | May 1, 2021 | |
| NCT04358991 | Completed | Pharmacokinetics of Ceftazidime-avibactam Among Critically-ill Patients Receiving CVVHDF | January 1, 2017 | December 31, 2019 | |
| NCT04380207 | Completed | Phase 1 | P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV | November 24, 2020 | August 31, 2022 |
| NCT04482569 | Completed | Phase 1 | Study to Evaluate Safety, Tolerability, and Pharmacokinetics of XNW4107 Alone or in Combination With Imipenem/Cilastatin | July 10, 2020 | September 30, 2021 |
| NCT04517695 | Completed | Blood Volume Assessment in COVID-19 and Bacterial Sepsis | August 1, 2020 | April 9, 2023 | |
| NCT04578873 | Completed | Phase 1 | Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults | April 13, 2021 | August 30, 2022 |
| NCT04642560 | Completed | Compliance With AntibIotic TherapY Guidelines in French PICUs | June 15, 2020 | September 30, 2022 | |
| NCT04688216 | Completed | Developing a Risk Assessment System of Multidrug-resistant Organisms Infection | January 1, 2020 | December 30, 2022 | |
| NCT04734431 | Completed | Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients | January 1, 2018 | January 1, 2020 | |
| NCT04777747 | Completed | The Role of Lactate in Viral and Bacterial Infection | January 1, 2021 | March 31, 2023 | |
| NCT04787562 | Completed | Phase 1 | Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function | February 25, 2021 | February 28, 2022 |
| NCT04801043 | Completed | Phase 1 | To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females. | March 2, 2021 | January 31, 2022 |
| NCT04802863 | Completed | Phase 1 | Intrapulmonary Pharmacokinetics of XNW4107, Imipenem and Cilastatin in Healthy Subjects | March 25, 2021 | September 30, 2021 |
| NCT04806776 | Completed | N/A | Frequence of Dressing Change and Bacterial Colonization in Pediatric Intensive Care Unit | April 7, 2021 | December 30, 2022 |
| NCT04808414 | Completed | Phase 1 | SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers | June 3, 2021 | July 14, 2022 |
| NCT04823026 | Completed | Host RNA Profiles to Detect Infections in Young Infants | May 15, 2020 | December 31, 2021 | |
| NCT04841369 | Completed | Phase 3 | Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) | April 13, 2021 | September 20, 2022 |
| NCT05072444 | Completed | Phase 1 | Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects | November 15, 2021 | November 23, 2021 |
| NCT05088421 | Completed | Phase 1 | A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers | November 5, 2021 | May 28, 2023 |
| NCT05100433 | Completed | N/A | Effect of Passive Ultrasonic Irrigation on Bacteria That Persist After Root Canal Preparation | March 5, 2018 | November 25, 2022 |
| NCT05106803 | Completed | Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan | August 1, 2019 | October 1, 2019 | |
| NCT05210920 | Completed | N/A | RBG: Regular, Bare, Gel: Does Type of Nail Polish Affect Bacterial Counts After Surgical Scrubbing? | May 28, 2021 | May 31, 2023 |
| NCT05226923 | Completed | Phase 1 | Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy Subjects | January 12, 2022 | October 1, 2022 |
| NCT05259683 | Completed | Febrile Infant Diagnostic Assessment and Outcome Study | August 1, 2022 | December 31, 2023 | |
| NCT05293418 | Completed | Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19 | October 1, 2020 | September 30, 2022 | |
| NCT05498363 | Completed | Bacteriophage Therapy of Difficult-to-treat Infections | January 1, 2008 | December 31, 2021 | |
| NCT05586438 | Completed | Phase 4 | Pharmacokinetics of Colistin in Critically-ill Patients With AKI Who Receive SLED | October 18, 2021 | October 31, 2022 |
| NCT00000811 | Completed | Phase 2 | A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children | November 2001 | |
| NCT05684718 | Completed | Phase 1 | To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100 | February 1, 2023 | October 31, 2023 |
| NCT05897801 | Completed | Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO | May 29, 2023 | January 31, 2024 | |
| NCT06046937 | Completed | Early Phase 1 | Monolaurin Ointment Versus Mupirocin Ointment | June 1, 2023 | July 15, 2023 |
| NCT06100848 | Completed | N/A | Hydrogen Peroxide Fumigation in Dental Office Environment | January 3, 2023 | September 25, 2023 |
| NCT06174519 | Completed | Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment | August 1, 2023 | December 1, 2023 | |
| NCT01337167 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) | April 19, 2011 | May 9, 2013 |
| NCT01340937 | Completed | Phase 3 | A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) | May 10, 2011 | July 26, 2013 |
| NCT01341639 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) | May 26, 2011 | March 13, 2013 |
| NCT01381848 | Completed | Phase 1 | A Study of Doripenem in Infants Less Than 12 Weeks of Age | October 2009 | April 2012 |
| NCT01402713 | Completed | Phase 2/Phase 3 | To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children | August 2011 | November 2013 |
| NCT01412801 | Completed | Phase 2 | Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings | September 2011 | December 2012 |
| NCT01480258 | Completed | Phase 3 | Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) | November 23, 2011 | October 9, 2013 |
| NCT01528969 | Completed | Phase 1/Phase 2 | Effect of Xylitol on Oral Microbiota in Children | March 2012 | May 2012 |
| NCT01553279 | Completed | Phase 3 | Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) | March 30, 2012 | September 27, 2013 |
| NCT01587937 | Completed | N/A | Hospital Wide Roll-Out of Antimicrobial Stewardship | April 2010 | April 2012 |
| NCT01608815 | Completed | Phase 3 | Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects | May 2012 | December 2012 |
| NCT01638702 | Completed | N/A | Study of Complication Rates Associated With PICC for Left vs Right | October 2012 | September 2015 |
| NCT01689207 | Completed | Phase 1 | To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) | September 2012 | December 2014 |
| NCT01702649 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects | August 2012 | November 2012 |
| NCT01744730 | Completed | Phase 1 | Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile | June 2013 | August 2014 |
| NCT01746654 | Completed | Phase 1/Phase 2 | Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients | December 2012 | December 2015 |
| NCT01751269 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects | December 2012 | July 2013 |
| NCT01772836 | Completed | Phase 1 | Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination | March 2013 | March 2013 |
| NCT01788449 | Completed | Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance | May 2005 | February 2007 | |
| NCT01819298 | Completed | Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy | March 2011 | June 2012 | |
| NCT01839175 | Completed | Phase 3 | Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination | April 2013 | February 2015 |
| NCT01839188 | Completed | Phase 3 | Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) | May 1, 2013 | March 19, 2014 |
| NCT01897779 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects | July 2013 | February 2014 |
| NCT01932034 | Completed | Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software | September 2012 | July 4, 2016 | |
| NCT01949103 | Completed | Phase 1 | TD-1607 MAD Study in Healthy Subjects | October 2013 | July 2014 |
| NCT01966055 | Completed | Phase 1 | Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents | December 2013 | September 2014 |
| NCT02066402 | Completed | Phase 3 | Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) | March 4, 2014 | April 18, 2016 |
| NCT02134834 | Completed | Phase 1 | A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 | May 2014 | November 2014 |
| NCT02146209 | Completed | Phase 1 | Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. | June 2014 | June 2014 |
| NCT02162199 | Completed | Phase 1 | A Single Dose Study of Debio 1450 in Healthy Subjects | June 2014 | October 2014 |
| NCT02214433 | Completed | Phase 1 | A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers | August 2014 | February 2015 |
| NCT02269319 | Completed | Phase 2 | MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection | February 2015 | September 2015 |
| NCT02294695 | Completed | Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients | October 2012 | October 2013 | |
| NCT02306330 | Completed | N/A | MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial | December 2014 | January 2016 |
| NCT02361866 | Completed | Phase 3 | To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults | May 2014 | October 2014 |
| NCT02378480 | Completed | Phase 3 | Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) | June 2015 | May 2016 |
| NCT02426918 | Completed | Phase 2 | Study of Debio 1450 for Bacterial Skin Infections | May 2015 | September 2016 |
| NCT04633603 | Enrolling by invitation | LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System | January 15, 2020 | December 31, 2023 | |
| NCT06404307 | Not yet recruiting | N/A | Self-administration in Outpatient Parenteral Antimicrobial Therapy Service | May 2024 | March 31, 2025 |
| NCT06103500 | Not yet recruiting | N/A | Integrated Clinical Decision Support for Empiric Antibiotic Selection in Sepsis | July 1, 2024 | March 31, 2025 |
| NCT05590195 | Not yet recruiting | Phase 3 | Effect of PreforPro® on Urinary and Vaginal Health | May 1, 2024 | June 1, 2025 |
| NCT06157242 | Not yet recruiting | Phase 1 | PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment | June 1, 2024 | June 1, 2025 |
| NCT05783661 | Not yet recruiting | Phase 4 | Trial Comparing Conventional Antibiotic Strategies Versus Regimens Guided by Epidemiological Surveillance in Infected Patients With Cirrhosis (SURVIC_STUDY) | August 2024 | August 2026 |
| NCT06377592 | Recruiting | Development and Accuracy Evaluation of Gram Staining Analysis AI | May 10, 2023 | March 31, 2027 | |
| NCT05914467 | Recruiting | Phase 4 | TDM-optimized Teicoplanin Dosing Versus Standard of Care | August 1, 2023 | December 30, 2024 |
| NCT06079775 | Recruiting | Phase 1 | P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants | January 30, 2024 | December 7, 2024 |
| NCT06354205 | Recruiting | N/A | Comparison of Salivary Procalcitonin (PCT) Levels and Serum PCT Levels | June 1, 2024 | April 1, 2025 |
| NCT05217537 | Recruiting | Phase 1 | Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections | April 6, 2022 | September 2024 |
| NCT00945152 | Recruiting | Phase 2 | Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) | July 15, 2011 | December 15, 2024 |
| NCT05840588 | Recruiting | N/A | Evaluation of the Impact of an Amoxicillin and Amoxicillin/Clavulanic Acid Resistant Probiotic on Key Clinical Outcomes in Children Treated With Amoxicillin or Amoxicillin/Clavulanic Acid | April 10, 2023 | December 31, 2023 |
| NCT05762094 | Recruiting | A Retrospective Study on Personalized Dosing Strategy of Patients Treated by Carbapenems: 2018-2021 | March 2023 | December 2023 | |
| NCT05722184 | Recruiting | Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa | June 8, 2023 | December 2024 | |
| NCT06322277 | Recruiting | N/A | Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccinations. | May 4, 2021 | March 31, 2025 |
| NCT02979951 | Recruiting | Fosfomycin i.v. for Treatment of Severely Infected Patients | December 2016 | December 2030 | |
| NCT05942157 | Recruiting | N/A | Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections | March 29, 2023 | December 31, 2025 |
| NCT05684705 | Recruiting | Phase 1 | Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100 | September 1, 2023 | December 2024 |
| NCT05645107 | Recruiting | Phase 3 | A Study to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment (SMT) Compared to Placebo Plus SMT to Prevent Infections in Participants With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia | December 26, 2022 | June 2026 |
| NCT03933748 | Recruiting | Therapeutic Drug Monitoring of Teicoplanin in Children | April 1, 2019 | December 2025 | |
| NCT05960383 | Recruiting | Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation | February 2, 2023 | November 1, 2024 | |
| NCT05336851 | Recruiting | Emergency PWAS in Respiratory Infectious Disease | April 11, 2023 | May 1, 2025 | |
| NCT02687906 | Recruiting | Phase 1 | Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections | July 2016 | June 2025 |
| NCT02655302 | Recruiting | N/A | Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD | July 4, 2018 | July 2028 |
| NCT05350813 | Recruiting | N/A | Impact of Procalcitonin-guided Algorithm on Early Discontinuation of Antibiotic Therapy | May 2, 2023 | February 2, 2025 |
| NCT05584683 | Recruiting | Phase 1 | A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection | August 9, 2023 | June 10, 2024 |
| NCT06319235 | Recruiting | Phase 1/Phase 2 | Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® | October 27, 2023 | December 31, 2025 |
| NCT05611905 | Recruiting | Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid | December 22, 2023 | November 26, 2027 | |
| NCT05587283 | Recruiting | Phase 1 | Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women | November 2, 2022 | May 2023 |
| NCT04263792 | Recruiting | Phase 1 | [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects | February 7, 2020 | January 2027 |
| NCT05998226 | Recruiting | N/A | VAT-2: Evaluation of a Virtual Antimicrobial Stewardship Team (VAT) on Antibiotic Prescriptions in Nursing Homes | June 1, 2023 | June 30, 2024 |
| NCT06025682 | Recruiting | Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO | April 4, 2024 | January 2025 | |
| NCT00431028 | Terminated | Phase 1/Phase 2 | Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery | September 2005 | March 2008 |
| NCT05942820 | Terminated | Phase 1 | The Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Adult Volunteers | August 30, 2023 | February 15, 2024 |
| NCT03696901 | Terminated | Xydalba Utilization Registry in Germany | November 21, 2018 | April 7, 2020 | |
| NCT00835783 | Terminated | Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation | November 2008 | December 2013 | |
| NCT02031588 | Terminated | Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients. | December 2012 | September 2015 | |
| NCT02527681 | Terminated | Phase 1 | Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics | November 22, 2016 | February 25, 2020 |
| NCT02688790 | Terminated | Phase 1 | Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection | April 1, 2016 | April 3, 2019 |
| NCT00493038 | Terminated | Phase 4 | Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis | February 2006 | January 2008 |
| NCT04783727 | Terminated | N/A | PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis | April 1, 2021 | November 1, 2022 |
| NCT03271580 | Terminated | Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing | February 1, 2020 | September 13, 2021 | |
| NCT03243864 | Unknown status | Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis | March 13, 2017 | October 21, 2020 | |
| NCT00190281 | Unknown status | Contrast-Enhanced US of Spleen, Liver and Kidney | August 2005 | ||
| NCT03941951 | Unknown status | N/A | Study to Optimize the Use of New Antibiotics | July 9, 2019 | December 31, 2022 |
| NCT02074865 | Unknown status | Children's Antibiotic Resistant Infections in Low Income Countries | September 2012 | ||
| NCT04864873 | Unknown status | N/A | Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing. | May 1, 2021 | May 2022 |
| NCT03667937 | Unknown status | Phase 4 | Effectiveness of a Hydrophobic Dressing for Microorganisms' Colonization and Infection Control of Vascular Ulcers | May 15, 2019 | April 30, 2021 |
| NCT02837081 | Unknown status | N/A | Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program | December 2015 | March 2017 |
| NCT04609384 | Unknown status | Nudging Effect of Timer on Surgical Rub | January 1, 2020 | January 1, 2023 | |
| NCT03931876 | Unknown status | Phase 1 | A Single Ascending Dose Study of AV-006 in Healthy Subjects | June 24, 2019 | November 1, 2019 |
| NCT05285046 | Unknown status | Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM | April 1, 2022 | February 28, 2023 | |
| NCT03915275 | Unknown status | Clinical Impact of 16S rDNA PCR | May 1, 2019 | May 2020 | |
| NCT03858387 | Unknown status | PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients | September 1, 2018 | December 31, 2021 | |
| NCT03857295 | Unknown status | Infections Following NeuroSurgery (INS) | March 11, 2019 | December 31, 2019 | |
| NCT04764058 | Unknown status | Phase 1/Phase 2 | Efficacy and Safety of Colistin Based Antibiotic Therapy | September 1, 2017 | September 1, 2021 |
| NCT03846921 | Unknown status | Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections | March 4, 2019 | March 2020 | |
| NCT03634904 | Unknown status | N/A | Serum Ceftazidime Concentrations in Hemodialysis Patients | September 15, 2018 | September 15, 2021 |
| NCT03079609 | Unknown status | N/A | The Search for Viral and Bacterial Etiology of Varicocele | July 2016 | December 2019 |
| NCT00945087 | Unknown status | N/A | Experimental Phage Therapy of Bacterial Infections | December 2005 | |
| NCT03204591 | Unknown status | Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury | July 20, 2017 | January 18, 2019 | |
| NCT03767374 | Unknown status | Risk-factors for Multidrug-resistant Bacteria Colonization Among Patients at High Risk of STIs | May 11, 2018 | December 31, 2019 | |
| NCT04328051 | Unknown status | N/A | Influence of the Implant-prosthetic Connection in the Marginal Bone Loss and Bacterial Leakage | June 13, 2018 | December 13, 2021 |
| NCT04254991 | Unknown status | A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection | May 30, 2016 | May 2020 | |
| NCT01159470 | Unknown status | The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children | September 2010 | September 2011 | |
| NCT05269121 | Withdrawn | Phase 1/Phase 2 | Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections | September 2022 | November 2024 |
| NCT04226001 | Withdrawn | Impact of a Carrier (Infection, Colonization) of Highly Bacteria Resistance on the Patient's Quality of Life Hospital Environment | November 16, 2020 | February 2021 | |
| NCT04502914 | Withdrawn | N/A | The Study on Bacterial Load Following Open-to-air Management in Burn Patients. | November 1, 2020 | June 9, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001424